An epidemiological study of clinical outcome of snakebite in children

---

Original Article

Author Details : Subburaman Sonraju Vinchu, Varun Kumar Ezhilarasan

Volume : 3, Issue : 1, Year : 2017

Article Page : 13-17

Suggest article by email

Get Permission

---

Abstract

Background: Snake bite is one of the commonest medical emergencies in India and most are found in the rural areas of India.
Aim of the Study: Assessment of clinical outcome of snake bite in children.
Results: Out of 65 children studied, males (66%) outnumbered females (34%). Rural(82%) area children were more susceptible than urban children(18%). Most common presenting symptom was history of bite (55%). Lower limb (55%) bites were more common. 72% were not aware of first aid measures. 18.5% of the victims were administered Anti Snake Venom (ASV) at primary health care level and the dosages were inadequate. Syndromic approach to snake bite was very useful. 65% of the victims had no signs of systemic envenomation. Among venomous snake bites, hemotoxic (23%) snake bites were more common followed by neurotoxic (12%) bites. The allergic reactions were usually mild (40%) which were counteracted by common drugs. Most common presenting symptom was history of bite (55%). 20 minute Whole blood clotting time(WBCT) was the most reliable test for hemotoxicity. ASV was the main stay of treatment.
Conclusion: The delay in appropriate treatment leads to significant morbidity and mortality. R.I.G.H.T first aid has to be taught to the public. The syndromic approach of snake bites has to be followed. The ASV is the mainstay of treatment. There should be no panic in treating allergic reactions. Good first aid, early referral, administration of adequate and timely dose of ASV, and timely management of allergic reactions can significantly reduce mortality rate.

Keywords: Snake bite, Envenomation, Antisnake venom, Anaphylaxis, Outcome

How to cite : Vinchu S S, Ezhilarasan V K, An epidemiological study of clinical outcome of snakebite in children. IP Int J Med Paediatr Oncol 2017;3(1):13-17

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.